KR102702552B1 - 결합 폴리펩타이드 및 이의 제조 방법 - Google Patents

결합 폴리펩타이드 및 이의 제조 방법 Download PDF

Info

Publication number
KR102702552B1
KR102702552B1 KR1020197021677A KR20197021677A KR102702552B1 KR 102702552 B1 KR102702552 B1 KR 102702552B1 KR 1020197021677 A KR1020197021677 A KR 1020197021677A KR 20197021677 A KR20197021677 A KR 20197021677A KR 102702552 B1 KR102702552 B1 KR 102702552B1
Authority
KR
South Korea
Prior art keywords
strand
cell
cdna
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197021677A
Other languages
English (en)
Korean (ko)
Other versions
KR20190111036A (ko
Inventor
재커리 슈라이버
그레고리 배브콕
루크 로빈슨
Original Assignee
비스테라, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 비스테라, 인크. filed Critical 비스테라, 인크.
Priority to KR1020247029164A priority Critical patent/KR20240133790A/ko
Publication of KR20190111036A publication Critical patent/KR20190111036A/ko
Application granted granted Critical
Publication of KR102702552B1 publication Critical patent/KR102702552B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020197021677A 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법 Active KR102702552B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020247029164A KR20240133790A (ko) 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662438712P 2016-12-23 2016-12-23
US62/438,712 2016-12-23
PCT/US2017/068204 WO2018119402A1 (en) 2016-12-23 2017-12-22 Binding polypeptides and methods of making the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020247029164A Division KR20240133790A (ko) 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법

Publications (2)

Publication Number Publication Date
KR20190111036A KR20190111036A (ko) 2019-10-01
KR102702552B1 true KR102702552B1 (ko) 2024-09-03

Family

ID=61054491

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020197021677A Active KR102702552B1 (ko) 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법
KR1020247029164A Pending KR20240133790A (ko) 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020247029164A Pending KR20240133790A (ko) 2016-12-23 2017-12-22 결합 폴리펩타이드 및 이의 제조 방법

Country Status (15)

Country Link
US (2) US11820979B2 (https=)
EP (1) EP3559028A1 (https=)
JP (2) JP7360324B2 (https=)
KR (2) KR102702552B1 (https=)
CN (1) CN110366557B (https=)
AU (1) AU2017382367B2 (https=)
BR (1) BR112019013096A2 (https=)
CA (1) CA3045696A1 (https=)
CL (2) CL2019001757A1 (https=)
CO (1) CO2019006663A2 (https=)
IL (2) IL315727A (https=)
MX (1) MX2019007356A (https=)
MY (1) MY201744A (https=)
RU (1) RU2019123063A (https=)
WO (1) WO2018119402A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3781677A4 (en) * 2018-04-16 2022-01-19 University of Massachusetts COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITTING
CN109161572B (zh) * 2018-07-05 2021-11-12 中国海洋大学 单链环状核酸及其制备方法和应用
WO2020097395A1 (en) 2018-11-08 2020-05-14 The Regents Of The University Of California Systems and methods for targeting cancer cells

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070141048A1 (en) 2003-09-18 2007-06-21 Oleksiewicz Martin B Method for linking sequences of interest
WO2013092716A1 (en) * 2011-12-21 2013-06-27 F. Hoffmann-La Roche Ag Rapid method for cloning and expression of cognate antibody variable region gene segments
WO2013188872A1 (en) * 2012-06-15 2013-12-19 The Board Of Regents Of The University Of Texas System High throughput sequencing of multiple transcripts of a single cell
WO2015166272A2 (en) * 2014-05-02 2015-11-05 Iontas Limited Preparation of libraries of protein variants expressed in eukaryotic cells and use for selecting binding molecules

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・２・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8905669D0 (en) 1989-03-13 1989-04-26 Celltech Ltd Modified antibodies
WO1991000906A1 (en) 1989-07-12 1991-01-24 Genetics Institute, Inc. Chimeric and transgenic animals capable of producing human antibodies
DE69120146T2 (de) 1990-01-12 1996-12-12 Cell Genesys Inc Erzeugung xenogener antikörper
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
DE69133557D1 (de) 1990-08-29 2007-03-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP1820858B1 (en) 1991-03-01 2009-08-12 Dyax Corporation Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
EP0519596B1 (en) 1991-05-17 2005-02-23 Merck & Co. Inc. A method for reducing the immunogenicity of antibody variable domains
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
DK1621554T4 (da) 1992-08-21 2012-12-17 Univ Bruxelles Immunoglobuliner blottet for lette kæder
US5851804A (en) 1996-05-06 1998-12-22 Apollon, Inc. Chimeric kanamycin resistance gene
CA2258570A1 (en) 1996-06-17 1997-12-24 Biodynamics Associates Method and kits for preparing multicomponent nucleic acid constructs
US20020086330A1 (en) 2000-01-31 2002-07-04 Rosen Craig A. Nucleic acids, proteins, and antibodies
EP1259601A2 (en) 2000-02-22 2002-11-27 Ahuva Nissim Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
HRP20080197T8 (hr) * 2003-09-18 2008-07-31 Symphogen A/S Postupak za povezivanje sekvenci od interesa
US20060199191A1 (en) 2004-12-13 2006-09-07 Demian Obregon Methods and compositions for the synthesis of RNA and DNA
CN101370832B (zh) 2005-12-02 2014-07-02 健泰科生物技术公司 结合多肽及其用途
BRPI0808551B1 (pt) * 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
DK2121920T3 (da) 2007-03-01 2011-11-21 Symphogen As Fremgangsmåde til kloning af sammenhørende antistoffer
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP3124497B1 (en) 2007-09-14 2020-04-15 Adimab, LLC Rationally designed, synthetic antibody libraries and uses therefor
EP2604279A1 (en) 2008-03-27 2013-06-19 ZymoGenetics, Inc. Compositions and methods for inhibiting PDGFRBETA and VEGF-A
WO2010005593A1 (en) * 2008-07-11 2010-01-14 President And Fellows Of Harvard College Systems and methods of droplet-based selection
CN102137928A (zh) 2008-08-29 2011-07-27 西福根有限公司 克隆禽源抗体的方法
US8497071B2 (en) 2009-06-29 2013-07-30 California Institute Of Technology Isolation of unknown rearranged T-cell receptors from single cells
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione
WO2011071943A1 (en) * 2009-12-07 2011-06-16 Prognosys Biosciences, Inc. Peptide display arrays
CA2799746C (en) 2010-05-17 2020-11-24 Sai Reddy Rapid isolation of monoclonal antibodies from animals
EP2640745B1 (en) * 2010-09-10 2018-11-07 MedImmune Limited Bivalent and bispecific anti-il6/anti-il23 antibodies
WO2012083225A2 (en) 2010-12-16 2012-06-21 Gigagen, Inc. System and methods for massively parallel analysis of nycleic acids in single cells
CN103732738A (zh) 2011-04-28 2014-04-16 小利兰斯坦福大学托管委员会 与样品相关的多核苷酸的鉴定
US20140243234A1 (en) 2011-08-03 2014-08-28 Texas Biomedical Research Institute Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
EP2783214A2 (en) 2011-11-23 2014-10-01 The Board of Regents of The University of Texas System Proteomic identification of antibodies
US9701959B2 (en) 2012-02-02 2017-07-11 Invenra Inc. High throughput screen for biologically active polypeptides
EP2626433B1 (en) 2012-02-09 2017-04-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for linking nucleic acids in a microsome from endoplasmatic reticuli
SG11201408128WA (en) 2012-06-15 2015-01-29 Adaptive Biotechnologies Corp Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
WO2014043813A1 (en) 2012-09-19 2014-03-27 British Columbia Cancer Agency Branch Immune repertoire profiling
GB2525568B (en) 2013-03-15 2020-10-14 Abvitro Llc Single cell barcoding for antibody discovery
KR20150132479A (ko) 2013-03-15 2015-11-25 어댑티브 바이오테크놀로지스 코포레이션 복합 유전자 세트에서의 독특하게 태그되고 재배열된 적응 면역 수용체 유전자
RU2578009C2 (ru) 2013-05-08 2016-03-20 Закрытое акционерное общество "ЕВРОГЕН" Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках
EP3041934A1 (en) * 2013-09-03 2016-07-13 Moderna Therapeutics, Inc. Chimeric polynucleotides
GB201402591D0 (en) 2014-02-14 2014-04-02 Memo Therapeutics Ag Method for recovering two or more genes, or gene products, encoding an immunoreceptor
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
US10202640B2 (en) 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
EP3517625B1 (en) 2014-05-22 2021-01-20 The University of British Columbia Methods for determining lymphocyte receptor chain pairs
EP3950944A1 (en) 2014-09-15 2022-02-09 AbVitro LLC High-throughput nucleotide library sequencing
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10513733B2 (en) 2015-03-23 2019-12-24 Board Of Regents, The University Of Texas System High throughout sequencing of paired VH and VL transcripts from B cells secreting antigen-specific antibodies
AU2016253964B2 (en) 2015-04-27 2022-07-07 Abvitro Llc Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigens
US9422547B1 (en) 2015-06-09 2016-08-23 Gigagen, Inc. Recombinant fusion proteins and libraries from immune cell repertoires
EP3443087B1 (en) * 2016-04-12 2024-09-18 Medimmune, LLC Immune repertoire mining

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070141048A1 (en) 2003-09-18 2007-06-21 Oleksiewicz Martin B Method for linking sequences of interest
WO2013092716A1 (en) * 2011-12-21 2013-06-27 F. Hoffmann-La Roche Ag Rapid method for cloning and expression of cognate antibody variable region gene segments
WO2013188872A1 (en) * 2012-06-15 2013-12-19 The Board Of Regents Of The University Of Texas System High throughput sequencing of multiple transcripts of a single cell
WO2015166272A2 (en) * 2014-05-02 2015-11-05 Iontas Limited Preparation of libraries of protein variants expressed in eukaryotic cells and use for selecting binding molecules

Also Published As

Publication number Publication date
JP7360324B2 (ja) 2023-10-12
CN110366557A (zh) 2019-10-22
US11820979B2 (en) 2023-11-21
WO2018119402A1 (en) 2018-06-28
JP2023169422A (ja) 2023-11-29
KR20240133790A (ko) 2024-09-04
CO2019006663A2 (es) 2019-06-28
AU2017382367B2 (en) 2024-11-21
CA3045696A1 (en) 2018-06-28
IL267565A (en) 2019-08-29
US20180201926A1 (en) 2018-07-19
CN110366557B (zh) 2024-04-09
MY201744A (en) 2024-03-15
JP2020511117A (ja) 2020-04-16
RU2019123063A (ru) 2021-01-26
CL2019001757A1 (es) 2019-11-29
KR20190111036A (ko) 2019-10-01
IL267565B1 (en) 2024-10-01
US20240141334A1 (en) 2024-05-02
RU2019123063A3 (https=) 2021-11-29
MX2019007356A (es) 2019-09-05
IL267565B2 (en) 2025-02-01
AU2017382367A1 (en) 2019-06-13
EP3559028A1 (en) 2019-10-30
IL315727A (en) 2024-11-01
BR112019013096A2 (pt) 2019-12-17
CL2022000454A1 (es) 2023-03-24

Similar Documents

Publication Publication Date Title
KR102943539B1 (ko) 인터류킨-2 작용제 및 이의 용도
JP7573441B2 (ja) ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法
JP6175590B1 (ja) 癌の治療に用いるための細胞傷害誘導治療剤
US20240141334A1 (en) Binding polypeptides and methods of making the same
CN110214152B (zh) 模块化四聚体双特异性抗体平台
CN110121510A (zh) 程序性细胞死亡(pd-1)的单结构域抗体
CN114456272A (zh) 靶向afp肽/mhc复合体的构建体及其用途
JP2017535257A (ja) 免疫応答およびがん治療の増強に使用するための組成物および方法
US20220267452A1 (en) Anti-mutation type fgfr3 antibody and use therefor
CN113423720A (zh) CAR文库和scFv的制造方法
JP7854423B2 (ja) Ｐｄ－ｌ１結合性作用剤およびその使用
NZ753978A (en) Binding polypeptides and methods of making the same
HK40015938A (en) Binding polypeptides and methods of making the same
HK40015938B (zh) 结合多肽及其制备方法
NZ795976A (en) Binding polypeptides and methods of making the same
HK40102796A (zh) 用於癌症治疗的诱导细胞损伤的治疗药物
HK1258783B (zh) 用於癌症治疗的诱导细胞损伤的治疗药物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190723

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201222

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230126

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20231129

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240530

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20240829

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240830

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240830

End annual number: 3

Start annual number: 1

PG1601 Publication of registration